OneSource Specialty Pharma informs about press release

10 Apr 2025 Evaluate

OneSource Specialty Pharma has informed that it enclosed a press release made by the Company with respect to Good Manufacturing Practices (GMP) certification by ANVISA, the Brazilian Health Regulatory Agency, for OneSource flagship Unit 2 facility, following a successful regulatory inspection from November 18, 2024 to November 22, 2024. The above information is also available on the website of the Company: https://www.onesourcecdmo.com/investorrelations/stock-exchange-intimation/.

The above information is a part of company’s filings submitted to BSE.

Onesource Specialty Share Price

1669.00 -16.55 (-0.98%)
08-Dec-2025 11:38 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1798.40
Dr. Reddys Lab 1275.70
Cipla 1509.15
Zydus Lifesciences 932.65
Lupin 2086.70
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×